CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Codexis, Inc.

CDXS
$234M
Micro Cap
NASDAQIndustrial Organic ChemicalsProtein engineering🇺🇸North AmericaREDWOOD CITY165 employees

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Website

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

CDXS News
Drug Pipeline

No drugs found in this phase.

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is Codexis, Inc.'s next FDA catalyst?

CatalystAlert tracks every upcoming catalyst for Codexis, Inc. (CDXS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track CDXS biotech catalysts?

Add CDXS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Codexis, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply